title: Response to letter to the Editors-Safety of long-term denosumab therapy.
authors.affiliation: Stony Brook Cancer Center, Stony Brook University, Stony Brook, NY, 11794-8151, USA. Alison.Stopeck@stonybrookmedicine.edu.
authors.forename: Alison T
authors.initials: AT
authors.lastname: Stopeck
authors.affiliation: Amgen Inc., One Amgen Center Drive, Thousand Oaks, CA, 91320, USA. djwarner@amgen.com.
authors.forename: Douglas J
authors.initials: DJ
authors.lastname: Warner
mesh_terms: D015519:Bone Density; D050071:Bone Density Conservation Agents; D000069448:Denosumab; D006801:Humans
chemical_list: D050071:Bone Density Conservation Agents; D000069448:Denosumab